Annuncio pubblicitario
Italia markets close in 2 hours 19 minutes
  • FTSE MIB

    33.938,01
    +308,80 (+0,92%)
     
  • Dow Jones

    38.675,68
    +449,98 (+1,18%)
     
  • Nasdaq

    16.156,33
    +315,33 (+1,99%)
     
  • Nikkei 225

    38.236,07
    -38,03 (-0,10%)
     
  • Petrolio

    78,65
    +0,54 (+0,69%)
     
  • Bitcoin EUR

    59.012,64
    -64,59 (-0,11%)
     
  • CMC Crypto 200

    1.367,23
    +54,60 (+4,16%)
     
  • Oro

    2.331,70
    +23,10 (+1,00%)
     
  • EUR/USD

    1,0789
    +0,0022 (+0,20%)
     
  • S&P 500

    5.127,79
    +63,59 (+1,26%)
     
  • HANG SENG

    18.578,30
    +102,38 (+0,55%)
     
  • Euro Stoxx 50

    4.957,76
    +36,28 (+0,74%)
     
  • EUR/GBP

    0,8567
    -0,0011 (-0,13%)
     
  • EUR/CHF

    0,9747
    +0,0012 (+0,12%)
     
  • EUR/CAD

    1,4731
    +0,0006 (+0,04%)
     

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc.

TARRYTOWN, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 7, 2023 at 3:00 p.m. ET.  All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors” section and the "Events and Presentations" tab, or by using the following link:

https://ir.prestigebrands.com/events-presentations/events

For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the event.

ANNUNCIO PUBBLICITARIO

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse and iconic portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact

Phil Terpolilli, CFA, 914-524-6819

irinquiries@prestigebrands.com